Atuka Inc. is a pharmaceutical startup dedicated to finding a cure for Parkinson’s disease through advanced preclinical neuroscience. With a team of highly experienced neuroscientists, the company has been collaborating with partners for over 20 years to expand the frontiers of Parkinson’s disease research and develop life-changing therapeutics. Founded by Dr. Jonathan Brotchie in 2003, Atuka has evaluated over 300 potential therapeutics and seen more than 30 of them progress to clinical trials, marking unparalleled experience in the field globally. The company has also worked with over 90 organizations, building a rich understanding of Parkinson’s disease and potential treatments through 400 preclinical projects. With diverse expertise and a commitment to ethical scientific research, Atuka operates from offices and facilities in Toronto and Suzhou. The company's slogan, "A cure for Parkinson’s, faster, through the world’s best preclinical neuroscience," exemplifies its relentless pursuit of finding innovative solutions for neurological disorders.
There is no investment information
No recent news or press coverage available for Atuka Inc..